Dr. Kavya Muddasani Reddy, MD

Dr. Reddy practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Reddy's NPI, 1427318682, was assigned on May 22, 2012. Dr. Reddy graduated from Saint Louis University School Of Medicine in 2012. Dr. Reddy holds California license A127553.

Dr. Reddy's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Reddy's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reddy is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Reddy's licenses on file in 2 states: California and North Carolina.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding, hemorrhoids and hepatitis c among the conditions Dr. Reddy treats.

CMS data shows 322 Medicare services from Dr. Reddy across 9 procedure codes in 2024, for 142 Medicare patients. Medicare paid $32,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 142 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 58, with 54% women.

In 2024, Dr. Reddy wrote 228 Medicare Part D claims for 75 patients. 70% of them were for generic drugs. CMS names the drug for 145 of them, across 7 drugs with 11 or more claims each, at $39,788 in total drug cost. In 2023, CMS named 139 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Reddy for performance year 2024, reported as part of a group. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth. CMS counts 46 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reddy, more than 62% of the clinicians it reports for that procedure.

CMS Open Payments shows 18 general payments to Dr. Reddy from 7 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 61% of the total. Boston Scientific Corporation paid the most, $1,707.

Dr. Reddy graduated from Saint Louis University School Of Medicine in 2012.

Dr. Reddy is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.